ArticleCureus2025
Balancing Endoscopy and Surgery in Choledocholithiasis: A 12-Year Real-World Analysis From a Brazilian Tertiary University Hospital.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Choledocholithiasis is a common biliary disorder, with endoscopic retrograde cholangiopancreatography (ERCP) as the preferred therapy. However, anatomical complexity, prior surgery, or severe cholangitis often require surgical intervention. Data from the Latin American tertiary centers remain scarce. Objective To evaluate the real-world management of choledocholithiasis in a Brazilian university hospital over 12 years, comparing outcomes between ERCP and surgical approaches. Methods This was a retrospective, single-center study including a convenience sample of 251 consecutive patients treated between 2011 and 2023. Patients were stratified into exclusive ERCP, upfront surgery, or surgery following ERCP failure. Demographic, clinical, laboratory, and procedural variables were analyzed, focusing on complications, length of stay, and mortality. Results ERCP was performed exclusively in 77.8% of patients, while 22.2% required surgery, half after failed ERCP. Surgical patients had higher rates of previous cholangitis (46.4% and 42.9% vs. 26.7%,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.